# S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

> **NCT00088972** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 8 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** celecoxib
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00088972
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study closed due to poor accrual.
- **Last updated:** 2018-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00088972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00088972, "S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00088972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*